Introduction
Background
Program Focus: CSC 2.0 aims to:
- Facilitate early initiation of Antiretroviral Therapy (ART)
- Track and re-engage individuals lost to follow-up (LFU)
- Support viral suppression
- Connect PLHIV to essential social entitlements
Targeted groups include newly diagnosed PLHIV, pregnant and lactating women, HIV-exposed infants, and those lost to follow-up, ensuring comprehensive care throughout the HIV treatment continuum.
Goals and Objectives
Improve the survival and quality of life of PLHIV by enhancing retention, adherence, and viral suppression.
Key Objectives: Aligned with NACP V, CSC 2.0 focuses on:
Ensuring 95% of PLHIV know their status and are on treatment
Achieving 95% viral load suppression among those on treatment
Ensuring 95% of pregnant and breastfeeding women with HIV achieve viral suppression to eliminate vertical transmission.
The Care & Support Centre complements ART centres by ensuring PLHIV stay engaged in care. Key areas include:
- Retention in HIV Care
- Viral Load Testing
- Index Testing
- Elimination of Vertical Transmission of HIV & Syphilis
CSC 2.0 provides essential support to ART centres, ensuring long-term retention and care continuity for PLHIV.
Implementation Strategy
Key Activities: The following activities are vital for achieving CSC 2.0’s objectives:
Activity | Description |
Intensified Follow-up of Newly Initiated PLHIV on ART | Ensure adherence and prevent loss to follow-up (LFU) in the first six months of ART. |
Tracking Linkage Loss from ICTC to ART Centres | Identify and link PLHIV diagnosed at ICTC but not yet enrolled in ART. |
Follow-up of MIS PLHIV | Re-engage PLHIV who missed their appointments, ensuring continuous treatment. |
Tracking LFU Patients | Focus on re-engaging LFU patients and supporting them through Enhanced Adherence Counselling (EAC). |
Viral Load Testing Follow-up | Ensure timely viral load testing for PLHIV, including pregnant women and those on 3rd line treatment. |
Family Member Follow-up for HIV Testing | Encourage HIV testing for spouses, partners, and children of PLHIV to facilitate early treatment initiation. |
Proactive Follow-up of Positive Pregnant Women (PPWs) and HIV-Exposed Infants (HEIs) | Link PPWs to ART, support adherence, and ensure HEIs receive ARV and EID testing. |
Follow-up of PLHIV with Co-Morbidities | Monitor PLHIV with comorbidities like TB, ensuring they remain stable on ART. |
CD4 Monitoring | Follow-up for PLHIV with CD4 <200 cells/mm³ to prevent treatment failure and complications. |
The Care & Support Centre 2.0 program is a strategic effort to enhance HIV care and support, ensuring that PLHIV receive the treatment, care, and social support they need to lead healthy lives. This initiative plays a vital role in achieving India’s goal of eliminating HIV and its impact by 2030.